The global market for treating dry eye syndrome is poised for significant expansion. Estimated at US$ 4.80 Billion in 2022, it is forecasted to experience a robust compound annual growth rate (CAGR) of 7.0% from 2022 to 2032. This growth trajectory is expected to culminate in an impressive valuation of US$ 9.44 Billion by the …